SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318771-09-000003
Filing Date
2009-02-20
Accepted
2009-02-19 17:51:04
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. FORM 10-K FOR THE PERIOD ENDING DECEMBER 31, 2008 form10-k_2008.htm 10-K 3311772
2 GENENTECH, INC. TAX REDUCTION INVESTMENT PLAN, AS AMENDED AND RESTATED ex10_9.htm EX-10.9 606299
3 AMENDMENT NO. 1 TO GENENTECH, INC. SUPPLEMENTAL PLAN ex10_19.htm EX-10.19 19280
4 AMENDMENT NO. 2 TO GENENTECH, INC. SUPPLEMENTAL PLAN ex10_20.htm EX-10.20 18409
5 AMENDMENT NO. 3 TO GENENTECH, INC. SUPPLEMENTAL PLAN ex10_21.htm EX-10.21 16769
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23_1.htm EX-23.1 9738
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_1.htm EX-31.1 11561
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_2.htm EX-31.2 11691
9 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T ex32_1.htm EX-32.1 11735
10 PERFORMANCE GRAPH graph_10k2008.gif GRAPHIC 8346
  Complete submission text file 0000318771-09-000003.txt   4030304
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09813 | Film No.: 09622605
SIC: 2834 Pharmaceutical Preparations